Dihexa vs Normoftal
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small synthetic peptide built from angiotensin IV, engineered at Washington State University to be orally active and to cross into the brain. The pitch is bold: it is studied as a procognitive compound that may rebuild synaptic connections, and lab claims of extreme potency made it a darling of the nootropic underground. The reality check: every supporting study is in cells or rodents, there are zero human clinical trials, and a foundational 2012 biochemistry paper describing its target was later retracted.
Also: Eye Peptide Bioregulator, Retina Peptide
Normoftal is an obscure Russian eye supplement from the Khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. Be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. We keep the claims minimal on purpose.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
- Normoftal has stronger research evidence (Human Trials) compared to Dihexa (Animal Studies).
Detailed Comparison
| Attribute | Dihexa | Normoftal |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Dihexa is derived from angiotensin IV, a fragment of the renin-angiotensin system that has long been linked to memory in animal work. The leading hypothesis is that it acts on the hepatocyte growth factor (HGF) and its receptor c-Met, a growth-factor system that drives the formation of new dendritic spines and synapses. In cultured hippocampal neurons, dihexa and related angiotensin IV analogs increase spine density, and that effect disappears when the HGF/c-Met system is blocked, which is the main evidence the pathway matters. It is worth being blunt that the exact molecular interaction has been contested, since the original paper proposing direct HGF binding was retracted, so the mechanism is best treated as a working hypothesis rather than settled fact. | Khavinson's bioregulator theory holds that very short peptides (two to four amino acids) extracted from or modeled on a specific tissue can act as tissue-specific signals, switching gene expression and protein synthesis back toward normal in that organ. Normoftal is the eye/retina version, described as containing a synthesized peptide (marketed as 'AKS-G,' reportedly lysine and glutamic acid) intended to support retinal cells. The proposed mechanism is that the peptide corrects an age- or disease-related 'peptide deficiency' and restores normal cellular function in the retina. This is a hypothesis from one school of research, not a mechanism confirmed by independent molecular studies, and the specific composition claims come from vendors rather than peer-reviewed identification. |
| Common Dosing | 5-20 mg oral or sublingual daily Once daily, effects can last up to 10 days | 2 capsules 1-2x daily 1-2x daily, before meals |
| Administration | Oral, sublingual, or intranasal | Oral capsules, before meals |
| Typical Duration | Cycles of 2-4 weeks | 30-day courses, repeat after 2-6 months |
| Best Time to Take | Morning | Morning and evening, before meals |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The published evidence on dihexa is entirely preclinical. Harding, McCoy and colleagues at Washington State University reported that metabolically stabilized angiotensin IV analogs, including dihexa, restored cognition in scopolamine-impaired and aged rats and stimulated synaptogenesis in cultured neurons (J Pharmacol Exp Ther, 2012 and follow-ups). A 2014 study tied the procognitive and synaptogenic effects of these analogs to the HGF/c-Met system. There are no registered human clinical trials and no published human safety or pharmacokinetic data, so dosing, long-term safety and whether any of the rodent benefit translates to people are all unknown. One important caveat for anyone reading the primary literature: the 2012 paper that first proposed dihexa as an HGF/Met modifier was formally retracted in 2024, which weakens the strongest mechanistic claim. Treat dihexa as an interesting research molecule with promising animal data and a notable evidence gap, not as a proven cognitive enhancer. | Normoftal is sold in Russia as a dietary supplement and is marketed for retinal degeneration, glaucoma, cataracts, diabetic retinopathy, and post-surgical recovery. Here is the part that matters most: it is not FDA-approved, and the evidence for Khavinson-style retinal bioregulators is heavily concentrated within Khavinson's own institute and clinical program, not replicated by independent international groups to modern standards. The related pharmaceutical Retinalamin is registered for clinical use in Russia, but that registration reflects the Russian system, not FDA or EMA review. There are essentially no rigorous, independent, placebo-controlled trials specific to Normoftal itself in mainstream literature. Treat the marketed eye-health benefits as unproven claims, and treat confidence in this compound as low. |
Frequently Asked Questions: Dihexa vs Normoftal
What is the difference between Dihexa and Normoftal?
Dihexa is a cognitive peptide that dihexa (n-hexanoic-tyr-ile-(6) aminohexanoic amide) is a small synthetic peptide built from angiotensin iv, engineered at washington state university to be orally active and to cross into the brain. the pitch is bold: it is studied as a procognitive compound that may rebuild synaptic connections, and lab claims of extreme potency made it a darling of the nootropic underground. the reality check: every supporting study is in cells or rodents, there are zero human clinical trials, and a foundational 2012 biochemistry paper describing its target was later retracted. Normoftal is a cognitive peptide that normoftal is an obscure russian eye supplement from the khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. we keep the claims minimal on purpose. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Dihexa or Normoftal?
Neither is universally "better" - the choice depends on your specific goals. Dihexa is typically used for cognitive purposes, while Normoftal is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Dihexa and Normoftal be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Dihexa and Normoftal together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.